Pancreatic Cancer Research

ResearcherAsahikawa Medical UniversityNo recent work listed

Junpei Sasajima

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5056544156. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 2 papers · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper

Papers 9

  1. HOPS-R01 phase II trial evaluating neoadjuvant S-1 therapy for resectable pancreatic adenocarcinoma. Co-author DOI 10.1038/s41598-022-14094-0↗
  2. Prognostic significance of skeletal muscle decrease in unresectable pancreatic cancer: Survival analysis using the Weibull exponential distribution model. Co-author DOI 10.1016/j.pan.2021.03.002↗
  3. Resection for pancreatic cancer metastases contributes to survival: A case report with sequential tumor genotype profiling during the long-term postoperative c… First author DOI 10.1097/md.0000000000020564↗
  4. Genetic Tracing of Clonal Expansion and Progression of Pancreatic Ductal Adenocarcinoma: A Case Report and Multi-Region Sequencing Analysis. Co-author DOI 10.3389/fonc.2020.00728↗
  5. Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features. Co-author DOI 10.1053/j.gastro.2018.10.029↗
  6. Genetic analysis of postoperative recurrence of pancreatic cancer potentially owing to needle tract seeding during EUS-FNB. Co-author DOI 10.1055/a-1034-7700↗
  7. Utility of "liquid biopsy" using pancreatic juice for early detection of pancreatic cancer. Co-author DOI 10.1055/a-0721-1747↗
  8. Hematogenous Gastric Metastasis of Pancreatic Cancer. Co-author DOI 10.1159/000444249↗
  9. Metachronous pancreatic cancer originating from disseminated founder pancreatic intraductal neoplasias (PanINs). Co-author DOI 10.1002/cjp2.8↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yusuke Mizukami · 7 shared papers, 2015–2021 · strength 0.55
  2. Toshikatsu Okumura · 6 shared papers, 2018–2021 · strength 0.51
  3. Tetsuhiro Okada · 5 shared papers, 2018–2021 · strength 0.44
  4. Hiroki Sato · 4 shared papers, 2018–2021 · strength 0.35
  5. Hidemasa Kawabata · 4 shared papers, 2018–2021 · strength 0.35
  6. Yuko Omori · 4 shared papers, 2018–2020 · strength 0.30
  7. Mikihiro Fujiya · 3 shared papers, 2019–2021 · strength 0.28
  8. Shinya Tanaka · 2 shared papers, 2019–2020 · strength 0.16
  9. Toru Furukawa · 2 shared papers, 2019–2020 · strength 0.16
  10. Yohei Kitano · 1 shared paper, 2022 · strength 0.10
  11. Tsuyoshi Hayashi · 1 shared paper, 2022 · strength 0.10
  12. Masafumi Imamura · 1 shared paper, 2022 · strength 0.10
  13. Hirotoshi Ishiwatari · 1 shared paper, 2022 · strength 0.10
  14. Shin Haba · 1 shared paper, 2022 · strength 0.10
  15. Yasutoshi Kimura · 1 shared paper, 2022 · strength 0.10
  16. Tõru Nakamura · 1 shared paper, 2022 · strength 0.10
  17. Hirofumi Kamachi · 1 shared paper, 2022 · strength 0.10
  18. Tomoya Iida · 1 shared paper, 2022 · strength 0.10
  19. Satoshi Hirano · 1 shared paper, 2022 · strength 0.10
  20. Akinobu Taketomi · 1 shared paper, 2022 · strength 0.10
  21. Masayo Motoya · 1 shared paper, 2022 · strength 0.10
  22. Masato Taniguchi · 1 shared paper, 2016 · strength 0.10
  23. Shion Tachibana · 1 shared paper, 2020 · strength 0.09
  24. Hiroshi Nishihara · 1 shared paper, 2019 · strength 0.07
  25. Koji Imai · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.